These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 29482174)

  • 1. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
    Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T
    Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway.
    Zhang H; Zhang X; Wu X; Li W; Su P; Cheng H; Xiang L; Gao P; Zhou G
    Cancer Lett; 2012 Oct; 323(1):106-113. PubMed ID: 22484497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
    Kang Y; Zhang S; Cao W; Wan D; Sun L
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes.
    Zhang H; Jing X; Wu X; Hu J; Zhang X; Wang X; Su P; Li W; Zhou G
    Anticancer Drugs; 2015 Aug; 26(7):706-15. PubMed ID: 26053275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
    Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
    Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
    Leith CP; Kopecky KJ; Godwin J; McConnell T; Slovak ML; Chen IM; Head DR; Appelbaum FR; Willman CL
    Blood; 1997 May; 89(9):3323-9. PubMed ID: 9129038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
    Wang H; Wang X; Hu R; Yang W; Liao A; Zhao C; Zhang J; Liu Z
    Cancer Gene Ther; 2014 Feb; 21(2):83-9. PubMed ID: 24434572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY; Gupta V; Patwardhan GA; Bhinge K; Zhao Y; Bao J; Mehendale H; Cabot MC; Li YT; Jazwinski SM
    Mol Cancer; 2010 Jun; 9():145. PubMed ID: 20540746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
    Liu X; Yan Y; Ma W; Wu S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
    Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
    Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription.
    Xia Z; Guo M; Liu H; Jiang L; Li Q; Peng J; Li JD; Shan B; Feng P; Ma H
    Curr Cancer Drug Targets; 2015; 15(6):519-32. PubMed ID: 25968898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
    Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.